AMY-101 as complement C3 inhibitor for periodontitis therapy: mechanisms, efficacy, and clinical translation. [PDF]
Li J, Xu Z, Ayre WN, Liu X.
europepmc +1 more source
Inhibition of complement C3 signaling ameliorates locomotor and visual dysfunction in autoimmune inflammatory diseases. [PDF]
Xu L+14 more
europepmc +1 more source
Objective Biomarkers of disease pathogenesis are critically needed for amyotrophic lateral sclerosis (ALS) to facilitate diagnosis and patient stratification into appropriate therapeutic trials. Proteomic studies offer significant potential to advance this, but reproducibility across laboratories is a key component toward identifying protein changes ...
Gabrielle L. Adler+2 more
wiley +1 more source
Activated Immune and Complement C3 Are Potential Contributors in MASH via Stimulating Neutrophil Extracellular Traps. [PDF]
Liu A, Deng X, Hou S, Xi Y, Xu K.
europepmc +1 more source
Cell-autonomous regulation of complement C3 by factor H limits macrophage efferocytosis and exacerbates atherosclerosis. [PDF]
Kiss MG+23 more
europepmc +1 more source
Complement komponent C3 nivåer i serum hos storfe. Genetisk innflytelse og sammenheng med total hemolytisk complement [PDF]
Mahin Basha Syed, Ø. Lie, H. Solbu
openalex +1 more source
Nanoparticles Functionalized with Polymer Brushes for Gene Delivery
The engineering of the next generation gene delivery vectors requires the precise control of the architecture and physicochemical interactions controlling the transport, targeting, uptake, and release of nucleic acid materials to targeted cells. Polymer brush‐functionalized nanomaterials offer unprecedented control over such design and properties, and ...
Carlos E. Neri‐Cruz, Julien E. Gautrot
wiley +1 more source
Immunotherapy Platform That Conjugates Antigen to Complement C3-Targeted Liposomes Induces a Robust Adaptive Immune Response. [PDF]
Barber RG+5 more
europepmc +1 more source
Complement C3 Enhances LPS-Elicited Neuroinflammation and Neurodegeneration Via the Mac1/NOX2 Pathway. [PDF]
Zhou R+8 more
europepmc +1 more source